Pioneering research from Royal Columbian Hospital Foundation shows a significant decrease in pneumonia rates and establishes a new benchmark for ICU infection prevention. Ondine Biomedical Inc. (AIM: OBI) is pleased to announce that Royal Columbian Hospital Foundation (“RCHF”)’s Advancing Innovation in Medicine (“AIM”) Research Team, at one of Canada’s leading [...]